M28 Capital Management as of June 30, 2022
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 13 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 30.2 | $27M | 8.3M | 3.25 | |
| Adagio Therapeutics (IVVD) | 23.5 | $21M | 6.4M | 3.28 | |
| Rocket Pharmaceuticals (RCKT) | 11.0 | $9.9M | 716k | 13.76 | |
| Stoke Therapeutics (STOK) | 7.8 | $7.0M | 527k | 13.21 | |
| Bridgebio Pharma (BBIO) | 4.7 | $4.2M | 466k | 9.08 | |
| Curis Com New | 4.7 | $4.2M | 4.2M | 0.98 | |
| Mirati Therapeutics | 4.6 | $4.1M | 61k | 67.12 | |
| Tg Therapeutics (TGTX) | 3.5 | $3.1M | 726k | 4.25 | |
| Leap Therapeutics | 3.4 | $3.1M | 2.7M | 1.15 | |
| Verve Therapeutics (VERV) | 3.1 | $2.7M | 179k | 15.28 | |
| Atara Biotherapeutics | 2.4 | $2.1M | 269k | 7.79 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.9 | $779k | 1.0M | 0.78 | |
| Neximmune | 0.2 | $215k | 133k | 1.61 |
